Acquisitions (Tables)

9 Months Ended

Sep. 30, 2018

Business Acquisition, Pro Forma Information

The following unaudited pro forma combined financial information for the three and nine months ended October 1, 2017 gives effect to the Vascular Solutions and NeoTract acquisitions as if they had occurred on January 1, 2016. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have occurred under the ownership and management of the Company.



	Three Months Ended		Nine Months Ended
	October 1, 2017		October 1, 2017
	(Dollars and shares in thousands, except per share)
Net revenue	$	568,437	$	1,660,591
Net income	$	52,909	$	157,249
Basic earnings per common share:
Net income	$	1.17	$	3.50
Diluted earnings per common share:
Net income	$	1.14	$	3.37
Weighted average common shares outstanding:
Basic	45,035		44,975
Diluted	46,587		46,673